Planning For Exchanges: Pharma Hopes For “Broad Enrollment,” But Timeline Causes Concern

For pharmaceutical companies, the barometer for measuring success of the health plan exchanges created under the health care reform law will be how well they encourage broad enrollment.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet